Tag: Biotechnology

Merck and Pfizer are the latest big pharma companies to invest in this booming area.

The decision to buy Reata signals a new era under CEO Chris Viehbacher, and Wall Street’s skepticism presents an opportunity.

Shares of Recursion Pharmaceuticals, Schrodinger and others that are implementing AI are surging.

Large drug companies need innovation to deal with the drug-pricing law. That is a boon to smaller biotech firms.

WSJ News ExclusiveFinanceFarallon has nominated three directors to the board of Exelixis

The drugmaker recently had a market value almost $18 billion as big pharmaceutical companies rely on acquisitions to expand sales.

MarketsHeard on the StreetAs AbbVie’s Humira faces copycat biologics, the biggest beneficiaries will be the middlemen negotiating and dispensing the ...

MarketsHeard on the StreetCompany’s decision to price its Covid-19 vaccine at $110-$130 per dose seeks to make up for lower ...

U.S. stock indexes pared losses after being on course for a fifth consecutive down day as investors weighed interest rates ...

Bio-Rad Laboratories is in talks to combine with fellow life-sciences company Qiagen NV in a deal that would be worth ...